Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors

Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors

US Patent 9540370 · Granted Jan 10, 2017

Estimated economic value: $139,904,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Selective superparamagnetic sintering and an ink suitable therefor2024
Increased particle loading by surface modification with polyethersilane2022
Fused heterocyclic compounds as S1P modulators2020
Fused heterocyclic compounds as S1P modulators2020
Tricyclic quinoline and quinoxaline derivatives2018
Tricyclic quinoline and quinoxaline derivatives2018
Tricyclic quinoline and quinoxaline derivatives2018
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors2018
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors2018
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors2018
Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors2018
NAMPT and ROCK inhibitors2018